New Zealand markets closed

Lyxor Stoxx Eurp 600 IndGd&Sv ETF AccA/I (INDP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.80-0.04 (-0.51%)
At close: 4:00PM EDT
7.85 +0.05 (+0.64%)
After hours: 07:41PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.84
Open7.93
Bid7.79 x 1300
Ask7.85 x 900
Day's range7.57 - 7.93
52-week range6.82 - 36.80
Volume283,236
Avg. volume4,653,882
Market cap42.167M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-4.70
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est52.00
  • GlobeNewswire

    Indaptus Therapeutics Receives Notice of Allowance for Strategic Patent

    Key Patent for Platform Technology to Treat or Inhibit HBV and HIV InfectionsNEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the United States Patent and Trademark Office has issued a notice of allowance for claims related to the Company’s platform technology. The patent, titled, “Methods of Treatment of Infections Using Bacteria,” (Application No. 16/584,644) provides broad protection for the application